Fabrication of chitosan-alginate polyelectrolyte complexed hydrogel for controlled release of cilnidipine: a statistical design approach

References

• Prabhakaran D, Jeemon P, Roy A. Cardiovascular diseases in India: Current epidemiology and future directions. Circulation. 2016;133:1605–1620.
   PubMed Web of Science ®Google Scholar
• Singh B, Sahu AK, Prasad RK, et al. Preparation and characterization of cilnidipine nanoparticles for oral antihypertensive drug using anti-solvent precipitation method. Der Pharmacia Lettre. 2016;8:296–307.
   Google Scholar
• Chandra KS, Ramesh G. The fourth-generation Calcium channel blocker: Cilnidipine. Indian Heart J. 2013;65:691–695.10.1016/j.ihj.2013.11.001
   PubMedGoogle Scholar
• Leung HS, Yao X, Leung FP, et al. Cilnidipine, a slow-acting Ca2+ channel blocker, induces relaxation in porcine coronary artery: role of endothelial nitric oxide and [Ca2+]. British J Pharmacol. 2006;147:55–63.10.1038/sj.bjp.0706450
   PubMed Web of Science ®Google Scholar
• Liu XQ, Zhao Y, Li D, et al. Metabolism and metabolic inhibition of cilnidipine in human liver microsomes. Acta Pharmaco Sin. 2003;24:263–268.
   PubMed Web of Science ®Google Scholar
• Wang JG, Kario K, Lau T, et al. Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientific statement from the Asian Pacific Heart Association. Hypertens Res. 2013;34:423–430.
   Web of Science ®Google Scholar
• Kontermann RE. Half-life extended biotherapeutics. Expert Opin Biol Ther. 2016;16:903–915.10.1517/14712598.2016.1165661
   PubMed Web of Science ®Google Scholar
• Hoshide S, Kario K, Ishikawa J, et al. ‘Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure. Hypertens Res. 2005;28:1003.10.1291/hypres.28.1003
   PubMed Web of Science ®Google Scholar
• Kitahara Y, Saito F, Akao M, et al. Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients. J Cardiovasc Pharmacol. 2004;43:68–73.10.1097/00005344-200401000-00011
   PubMed Web of Science ®Google Scholar
• Ilium L. Chitosan and its use as a pharmaceutical excipient. Pharm Res. 1998;15:1326–1331.10.1023/A:1011929016601
   PubMed Web of Science ®Google Scholar
• Il’ina AV, Varlamov VP. Chitosan-based polyelectrolyte complexes: a review. App Biochem Microbiol. 2005;41:5–11.10.1007/s10438-005-0002-z
   Web of Science ®Google Scholar
• Dakhara S, Anajwala C. Polyelectrolyte complex: a pharmaceutical review. Sys Rev Pharm. 2010;1:121.10.4103/0975-8453.75046
   Google Scholar
• Pawar SN, Edgar kJ. Alginate derivatization: a review of chemistry, properties and applications. Biomaterials. 2012;33:3279–3305.10.1016/j.biomaterials.2012.01.007
   PubMed Web of Science ®Google Scholar
• Ulery BD, Nair LS, Laurencin CT. Biomedical applications of biodegradable polymers. J Polym Sci B Polym Phys. 2011;49:832–864.10.1002/polb.22259
   PubMed Web of Science ®Google Scholar
• Bajpai SK, Sharma S. Investigation of swelling/degradation behavior of alginate beads cross-linked with Ca2+ and Ba2+ ions. React Funct Polym. 2004;59:129–140.10.1016/j.reactfunctpolym.2004.01.002
   Web of Science ®Google Scholar
• Rasool BK, Fahmy S. Development of coated beads for oral controlled delivery of cefaclor: In vitro evaluation. Acta Pharmaceut. 2013;63:31–44.
   PubMed Web of Science ®Google Scholar
• Luo Y, Wang Q. Recent development of chitosan-based polyelectrolyte complexes with natural polysaccharides for drug delivery. Int J Biol Macromolec. 2014;64:353–367.10.1016/j.ijbiomac.2013.12.017
   PubMed Web of Science ®Google Scholar
• Thünemann AF, Müller M, Dautzenberg H, et al. Polyelectrolyte complexes. In: Polyelectrolytes with defined molecular architecture II’. 1st ed. Berlin: Springer; 2004. p. 113–171.10.1007/b10951
   Google Scholar
• Petrak K. Review: polyelectrolyte complexes in biomedical applications. J Bioact Compat Polym. 1986;1:202–219.10.1177/088391158600100207
   Google Scholar
• Nadpara NP, Thumar RV, Kalola VN, et al. Quality by design (Qbd): a complete review. Int J Pharm Sci Rev Res. 2012;17:20–28.
   Google Scholar
• Chowdary KP, Shankar KR, Kumar PS. Recent research on QbD approach in formulation development: a review. Int J Chem Sci Techn. 2014;4:282–292.
   Google Scholar
• Rathore AS. Roadmap for implementation of quality by design (QbD) for biotechnology products. Trends Biotechnol. 2009;27:546–53.10.1016/j.tibtech.2009.06.006
   PubMed Web of Science ®Google Scholar
• Dangre P, Badhe R, Shorolkar S, et al. Formulation, evaluation and optimization of fungal alpha amylase loaded alginate bead. J Adv Pharm Res. 2013;4:74–85.
   Google Scholar
• Srinatha A, Pandit JK. Alternate polyelectrolyte coating of chitosan beads for extending drug release. Drug Delivery. 2008;15:193–99.10.1080/10717540801952654
   PubMed Web of Science ®Google Scholar
• Higuchi T. Mechanism of sustained action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145–1149.10.1002/jps.2600521210
   PubMed Web of Science ®Google Scholar
• Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60:110–111.
   PubMedGoogle Scholar
• Korsmeyer RW, Gurny R, Doelker EM, et al. Mechanism of solute release from porous hydrophilic matrices. Int J Pharm. 1983;15:25–35.10.1016/0378-5173(83)90064-9
   Web of Science ®Google Scholar
• Sapate KA, Dangre PV, Godbole MD. Formulation and statistical optimization of multiparticulate lafutidine loaded gastroretentive drug delivery system using 32 factorial design. Indian Drug. 2014;51:43–54.
   Google Scholar
• Rasool BK, Fahmy SA. Development of coated beads for oral controlled delivery of cefaclor: In vitro evaluation. Acta Pharm. 2013;63:31–44.
   PubMed Web of Science ®Google Scholar
• Mokale V, Jitendra N, Yogesh S, et al. Chitosan reinforced alginate controlled release beads of losartan potassium: design, formulation and in vitro evaluation. J Pharm Investig. 2014;44:243–252.10.1007/s40005-014-0122-7
   Google Scholar
• Shruti C, Gayathri VP, Sanjay KM. Release modulating hydrophilic matrix systems of losartan potassium: optimization of formulation using statistical experimental design. Eur J Pharm Biopharm. 2007;66:73–82.
   PubMed Web of Science ®Google Scholar